Zobrazeno 1 - 10
of 468
pro vyhledávání: '"R. Rokicka-Milewska"'
Autor:
Anna Klukowska, A. Obitko-Płudowska, K. Niedzielska, I. Malinowska, P. Łaguna, R. Rokicka-Milewska
Publikováno v:
Haemophilia. 9:642-645
Summary. We describe the case of a previously healthy 8-year-old non-haemophilic boy who developed a factor VIII inhibitor of unknown origin. The symptoms of this disease were haemorrhages in the muscles of the right thigh, numerous bruises and a lar
Autor:
D, Josić, L, Hoffer, A, Buchacher, H, Schwinn, W, Frenzel, L, Biesert, H P, Klöcking, P, Hellstern, R, Rokicka-Milewska, A, Klukowska
Publikováno v:
Thrombosis Research. 100:433-441
The paper describes the production of a prothrombin complex concentrate (PCC) with high virus safety and a well-balanced content of vitamin K-dependent clotting factors and inhibitors. Solid-phase extraction is followed in a second step by optimized
Autor:
A Adamowicz-Salach, A Zdziebłowska-Pawińska, Brojer E, Loch T, B Walewska-Zielecka, K Pawelec, R Rokicka-Milewska
Publikováno v:
Haemophilia. 5:436-440
In 80% of children with haemophilia treated in our department, screening tests showed the presence of antibodies against the hepatitis C virus (HCV). HCV RNA was detected in serum in 41% of cases. In 20% of cases there were periodic increases in the
Autor:
Stanislaw Lopaciuk, Anna Klukowska, R. Rokicka-Milewska, Pawel Laguna, Jerzy Windyga, W. G. Struff, R. Kotitschke, D. M. Wolf, A. B. Skotnicki
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 10(5)
Summary. Clinical efficacy, safety and pharmacokinetic properties of the high-purity double-virus inactivated plasma-derived factor VIII concentrate Haemoctin® SDH (pdFVIII) were evaluated in three prospective open-label uncontrolled studies in prev
Autor:
A, Klukowska, P, Łaguna, A, Obitko-Płudowska, K, Niedzielska, I, Malinowska, R, Rokicka-Milewska
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 9(5)
We describe the case of a previously healthy 8-year-old non-haemophilic boy who developed a factor VIII inhibitor of unknown origin. The symptoms of this disease were haemorrhages in the muscles of the right thigh, numerous bruises and a large haemat
Autor:
Agnieszka Krauze, Danuta Sońta-Jakimczyk, W. Balwierz, Jerzy R. Kowalczyk, M. Matysiak, A. Hicke, M. Kaczmarek-Kanold, Barbara Sikorska-Fic, A. Ploszynska, Mariusz Wysocki, K. Kałwak, Kołecki P, Alicja Chybicka, Jacek Wachowiak, Anna Balcerska, Hanna Wisniewska-Slusarz, R. Rokicka-Milewska, M. Cwiklinska, Bogusławska-Jaworska J
Publikováno v:
Transplantation in Hematology and Oncology II ISBN: 9783642626609
Philadelphia positive chronic myeloid leukemia (CML Ph+) is a malignant clonal hematological disease of pluripotent stem cell representing 2–5% of all childhood leukemias [2]. The incidence of CML increases with age and is 1 per 100 000 at the age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b52b8189ff991d940d2192a7fef6abc
https://doi.org/10.1007/978-3-642-55774-3_25
https://doi.org/10.1007/978-3-642-55774-3_25
Publikováno v:
Haematology and Blood Transfusion Hämatologie und Bluttransfusion ISBN: 9783642639494
Intensive chemotherapy in acute lymphoblastic leukaemia leads to present relapse. Almost in all the cases relapse is due to original leukaemia clone proliferation and only in few cases different leukaemia clone is being formed. The main problem uncer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56f960c8b4f9d89843f4bf7c47c75a3f
https://doi.org/10.1007/978-3-642-59358-1_59
https://doi.org/10.1007/978-3-642-59358-1_59
Autor:
J, Styczyński, M, Wysocki, W, Balwierz, R, Rokicka-Milewska, M, Matysiak, A, Balcerska, A, Kowalczyk, J, Wachowiak, D, Sońta-Jakimczyk, A, Chybicka
Publikováno v:
Neoplasma. 49(3)
Resistance to glucocorticoids is nowadays one of the strongest adverse risk factors in the treatment of childhood acute lymphoblastic leukemia (ALL). Differential in vitro antileukemic activity of various glucocorticoids and their cross-resistance pa
Autor:
M, Samardakiewicz, J, Kowalczyk, M, Antonowicz, U, Budzińska-Skowronska, J, Boguslawska-Jaworska, M, Mazurowa, A, Mazur, R, Rokicka-Milewska, A, Bukowska-Posadzy, P, Kołecki, E, Maroczkaniec, D, Slazak, D, Sońta-Jakimczyk, E, Szweda, J, Armata, W, Budziński, A, Balcerska
Publikováno v:
Medycyna wieku rozwojowego. 4(1 Suppl 2)
Intensive chemotherapy programme in children with cancer may result in psychological mal adjustment. Treatment facilities as well as psychological support are of great importance to minimize these side effects. In 1998 the programme of psychological